Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

MDxHealth (MDXH) EBIT Margin: 2021-2025

Historic EBIT Margin for MDxHealth (MDXH) over the last 5 years, with Sep 2025 value amounting to 96.18%.

  • MDxHealth's EBIT Margin rose 231.00% to 96.18% in Q3 2025 from the same period last year, while for Sep 2025 it was 108.13%, marking a year-over-year decrease of 722.00%. This contributed to the annual value of 27.45% for FY2024, which is 1148.00% up from last year.
  • As of Q3 2025, MDxHealth's EBIT Margin stood at 96.18%, which was down 30.94% from 139.26% recorded in Q2 2025.
  • Over the past 5 years, MDxHealth's EBIT Margin peaked at 101,674.01% during Q2 2022, and registered a low of 93.86% during Q3 2024.
  • Moreover, its 3-year median value for EBIT Margin was 101.45% (2024), whereas its average is 108.74%.
  • Per our database at Business Quant, MDxHealth's EBIT Margin skyrocketed by 1,251,909bps in 2022 and then tumbled by 10,157,013bps in 2023.
  • MDxHealth's EBIT Margin (MRQ) stood at 139.63% in 2021, then fell by 24bps to 106.81% in 2022, then rose by 7bps to 114.71% in 2023, then dropped by 12bps to 101.45% in 2024, then fell by 5bps to 96.18% in 2025.
  • Its EBIT Margin was 96.18% in Q3 2025, compared to 139.26% in Q2 2025 and 94.35% in Q1 2025.